What is the management approach for a patient presenting with joint pains and purpuric rash, suggestive of Henoch-Schonlein purpura (HSP)?

Henoch-Schönlein Purpura (HSP) Clinical Summary

Diagnosis

Your patient's presentation of joint pain and purpuric rash is highly suggestive of Henoch-Schönlein Purpura, an IgA-mediated systemic small-vessel vasculitis that requires confirmation through specific clinical criteria and consideration of skin biopsy for definitive diagnosis. 1, 2

Diagnostic Criteria

• Palpable purpura (non-thrombocytopenic) is the hallmark finding, typically appearing on lower extremities and buttocks 3, 4, 2
• Diagnosis requires purpura PLUS at least one of the following 2:
  • Diffuse abdominal pain
  • Arthritis or arthralgia (present in your patient)
  • Renal involvement (hematuria and/or proteinuria)
  • Biopsy showing predominant IgA deposition

Essential Diagnostic Workup

• Skin biopsy with immunofluorescence should be performed to confirm IgA deposits in vessel walls, as this is sine qua non for diagnosis and prevents both missed diagnoses and unnecessary follow-up 1
• Urinalysis with microscopy to detect hematuria, proteinuria, and red blood cell casts 3, 2
• Serum creatinine and BUN to assess renal function 3
• Serum IgA levels (often elevated) 5
• Fecal occult blood test to screen for gastrointestinal involvement 3, 5
• Complete blood count to confirm normal platelet count (distinguishes from thrombocytopenic purpura) 4

Clinical Manifestations to Monitor

Organ System Involvement

• Skin: Non-blanching purpuric rash on lower extremities and buttocks (100% of cases) 3, 4, 2
• Joints: Migratory polyarthralgias or arthritis, typically affecting knees and ankles 3, 4, 2
• Gastrointestinal: Colicky abdominal pain, which can precede rash; risk of intussusception, bleeding from terminal ileum, or Meckel's diverticulum 3, 5, 4
• Renal: Hematuria and proteinuria; up to 20% develop chronic renal failure after 20 years, with highest risk (>50%) when presenting with combined nephrotic-nephritic syndrome 1, 2

Rare but Serious Complications

• Cardiac: Arrhythmias including atrial fibrillation and non-sustained ventricular tachycardia from cardiac vasculitis 3
• Neurological: Proximal muscle weakness, tremors, and clonus 3
• Renal: Crescentic glomerulonephritis requiring aggressive immunosuppression 3

Management Approach

Mild Disease (Rash and Arthralgia Only)

• Supportive care is the mainstay, as most cases are self-limited with average duration of 4 weeks 2
• Acetaminophen for joint pain 6, 7
• NSAIDs (naproxen 500 mg twice daily or meloxicam 7.5-15 mg daily) for 4-6 weeks if no contraindications 7
• Rest and elevation of affected extremities 2

Moderate Disease (Severe GI Pain or GI Hemorrhage)

• Oral corticosteroids (prednisone 10-20 mg daily or 0.5-1 mg/kg for severe symptoms) should be considered for severe gastrointestinal pain and hemorrhage 7, 2
• Current evidence does NOT support universal corticosteroid treatment for all HSP patients 2
• Early steroid treatment does NOT reduce incidence or severity of nephropathy 2

Severe Renal Involvement

• For severe nephritis or proteinuria persisting >3 months, add ACE inhibitor or angiotensin receptor blocker to corticosteroids to prevent secondary glomerular injury 2
• IV cyclophosphamide for crescentic glomerulonephritis with >75% glomerular involvement 3
• Serial monitoring of renal function every 4-6 weeks 7

Critical Monitoring Requirements

Short-Term (First 4 Weeks)

• Monitor for gastrointestinal complications: Severe abdominal pain may indicate intussusception or GI bleeding requiring urgent endoscopy 3, 4
• Serial urinalysis to detect new-onset or worsening renal involvement 2
• Blood pressure monitoring for hypertension 2

Long-Term Follow-Up

• Renal surveillance is mandatory even after apparent complete recovery, as renal signs can manifest years after initial presentation 1, 2
• Urinalysis and blood pressure checks at 1,3,6, and 12 months, then annually for at least 5 years 2
• Risk of chronic renal failure persists even with mild initial renal symptoms 1

Prognosis

Most cases have excellent outcomes with complete resolution, but renal involvement is the most important prognostic factor determining long-term morbidity and mortality 2. The disease is more severe in adolescents compared to younger children, requiring closer monitoring for systemic complications 3.